Educational intervention to improve the inhalation technique in patients with chronic obstructive pulmonary disease

ISRCTN ISRCTN60147249
DOI https://doi.org/10.1186/ISRCTN60147249
Secondary identifying numbers PI10/02384
Submission date
06/07/2011
Registration date
04/08/2011
Last edited
11/02/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
An inhaler is a device holding a medicine that you take by breathing in (inhaling). The delivery of drugs through inhalers has revolutionized the treatment of patients with respiratory (lung) diseases. The effectiveness of inhaled drugs can be influenced by many factors including age, sex, educational level, duration of the disease, type of inhaler, a correct technique or the use of multiple devices. Misuse of inhalers is a significant problem both for asthma and chronic obstructive pulmonary disease (COPD) because the consequence is a decrease in the effect of the drugs, causing a worse control of symptoms and therefore no effective control of the disease. The aim of this study is to evaluate the effectiveness of two educational interventions to improve the technique of drug inhalation in patients with COPD.

Who can participate?
Patients aged over 18 diagnosed with COPD who use inhaled therapy.

What does the study involve?
Participants are randomly allocated into three groups. The first group receives a leaflet about the correct inhalation technique. The second group receives the same leaflet and also instructor training about the correct inhalation technique. The third group receives treatment as usual. All participants attend follow-up appointments 3, 6 and 12 months later. The appointments are about 20 - 30 minutes long, depending on the group.

What are the possible benefits and risks of participating?
There are no risks for the participants

Where is the study run from?
Primary care centres in Málaga (Spain)

When is the study starting and how long is it expected to run for?
March 2011 to December 2013

Who is funding the study?
Instituto de Salud Carlos III (Ministerio de Ciencia e Innovación, Gobierno de España) (Spain)

Who is the main contact?
Dr D. José Leiva Fernández
mariap.barnestein.exts@juntadeandalucia.es

Contact information

Dr José Leiva Fernandez
Scientific

Unidad Docente Medicina Familiar y Comunitaria
Distrito Sanitario Málaga
Plaza Hospital Civil s/n Pabellón 6 2ª planta
Málaga
29009
Spain

Phone +34 (0)951 290 310
Email mariap.barnestein.exts@juntadeandalucia.es

Study information

Study designMulticenter randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEfficacy of two educational interventions about inhalation technique in patients with Chronic Obstructive Pulmonary Disease (COPD) - a randomized controlled trial
Study acronymTIEPOC
Study objectivesThe application of two educational interventions in patients with COPD who use inhaled therapy will increase the number of patients who perform a correct inhalation technique by at least 25%
Ethics approval(s)1. Ethical Committees of Distrito Sanitario Málaga, 21/12/2010
2. Área Sanitaria Málaga Este-Axarquía, 16/02/2010
3. Autonomic Clinical Assays Committee, 25/01/2011
Health condition(s) or problem(s) studiedChronic obstructive pulmonary disease
InterventionThe study is divided into three arms by block randomization: control, intervention A and intervention B:
1. Intervention A: written information
1.1. We will give written information about inhalation technique to the patient
1.2. We will design a leaflet about the correct inhalation technique, containing the main devices that patients use in our area
2. Intervention B: written information about inhalation technique and instructor training
2.1. We will give written information about inhalation technique to the patient (leaflet described above) and we are going to train the patient about the correct inhalation technique
3. Control group: treatment as usual
4. The appointments are approximately 20 - 30 minutes, depending on the arm of study
5. When the participant been located in an intervention arm the visit will be more detailed
6. The follow-up is the same for all arms and will be for 12 months

Visit schedule:
Intervention Group A and B:
Visit of inclusion: all the study data will be recorded and the inhalator technique will be tested
Visit 1: It will take place 3 months after the intervention. Primary and secondary outcomes (not spirometry and quality of life) will be measured and encouraging work about inhalers techniques and motivational aspects related with this will be individually applied.
Visit 2: It will take place 6 months after the intervention. Primary and secondary outcomes (not spirometry and quality of life) will be measured and encouraging work about inhalers techniques and motivational aspects related with this will be individually applied.
Visit 3: I will take place 12 months after the intervention. All the study data will be recorded and encouraging work about inhalers techniques and motivational aspects related with this will be individually applied.
Control Group:
Visit of inclusion: all the study data will be recorded and the inhalator technique will be tested.
Visit 1: It will take place 3 months after the intervention. Primary and secondary outcomes (not spirometry and quality of life) will be measured.
Visit 2: It will take place 6 months after the intervention. Primary and secondary outcomes (not spirometry and quality of life) will be measured.
Visit 3: I will take place 12 months after the intervention. All the study data will be recorded.
Intervention typeOther
Primary outcome measure1. Performance of correct inhalation technique
2. The correct inhalation technique will be measured by an investigator following SEPAR guidelines
Secondary outcome measures1. Pick flow measured at all visits
2. Dyspnea (Baseline dyspnea index (IDB) and Modified Medical Research Council (MMRC) questionnaires), measured at all visits
3. Functional status (spirometry), measured at visit of inclusion, visit 2 and visit 4.
4. Quality of life (St George and SeguiEPOC questionnaires), measured at visit of inclusion, visit 2 and visit 4
Overall study start date15/03/2011
Completion date31/12/2013

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants296
Key inclusion criteria1. Confirmed COPD diagnosis by spirometry (SEPAR guidelines)
2. Belonging to the selected Primary Care Centers in Malaga area
3. Use of inhaled therapy
4. Accepted to participate in the study and given informed consent
5. Aged over 18 years
6. Male or female participants
Key exclusion criteria1. Diagnosis of other respiratory conditions which are not included in the COPD definition
2. Cognitive impairment problems
Date of first enrolment15/09/2011
Date of final enrolment31/12/2013

Locations

Countries of recruitment

  • Spain

Study participating centre

Unidad Docente Medicina Familiar y Comunitaria
Málaga
29009
Spain

Sponsor information

Instituto de Salud (Instituto de Salud Carlos III, MInisterio de Ciencia e Innovación) (Spain)
Government

Sinesio Delgado nº 6
Madrid
28029
Spain

Phone +34 (0)918 222 100
Email oficina.informacion@isciii.es
Website http://www.isciii.es
ROR logo "ROR" https://ror.org/00ca2c886

Funders

Funder type

Government

Instituto de Salud (Instituto de Salud Carlos III, MInisterio de Ciencia e Innovación) (Spain)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

11/02/2016: Plain English summary added.